Breaking News Instant updates and real-time market news.

AMED

Amedisys

$116.80

2.88 (2.53%)

04:55
08/15/18
08/15
04:55
08/15/18
04:55

Amedisys management to meet with Oppenheimer

Meetings to be held in San Francisco August 14-15 hosted by Oppenheimer.

  • 15

    Aug

  • 16

    Aug

  • 17

    Aug

  • 22

    Aug

  • 22

    Aug

AMED Amedisys
$116.80

2.88 (2.53%)

07/03/18
BOFA
07/03/18
UPGRADE
Target $97
BOFA
Buy
Amedisys upgraded to Buy on reimbursement clarity at BofA/Merrill
As previously reported, BofA/Merrill upgraded Amedisys to Buy from Neutral and raised its price target to $97 from $88. Analyst Joanna Gajuk said last night's CMS proposal increased reimbursement visibility for the home health industry calling for a +2.1% rate update in 2019, the best update since 2007 following nine consecutive years of cuts. Additionally, the analyst said the proposed changes for 2020 appear manageable and provide clarity for the industry for-profits. Gajuk believes Amedisys is well positioned for the changes as its low leverage provides upside from capital deployment and has ample capacity to pursue acquisitions.
07/03/18
07/03/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Albemarle (ALB) upgraded to Buy from Neutral at Goldman Sachs with analyst Robert Koort saying the selloff in companies tied to lithium is overdone. 2. Veon (VEON) upgraded to Overweight from Neutral at JPMorgan with analyst Alexei Gogolev stating that the company shed its Italian business at a "very attractive price". 3. Roku (ROKU) upgraded to Outperform from Perform at Oppenheimer with analyst Jason Helfstein saying the "rapid adoption" of The Roku Channel gives him incremental confidence in the channel's ability to garner viewership on other platforms. 4. Amedisys (AMED) upgraded to Buy from Neutral at BofA/Merrill with analyst Joanna Gajuk stating that last night's CMS proposal increased reimbursement visibility for the home health industry calling for a +2.1% rate update in 2019, the best update since 2007 following nine consecutive years of cuts. 5. NetEase (NTES) upgraded to Overweight from Underweight at JPMorgan with analyst Alex Yao saying he expects NetEase to end a six-quarter "earnings downgrade cycle" with its "lackluster" earnings growth starting to recover in Q2 and peaking in Q1 of 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/01/18
OPCO
08/01/18
NO CHANGE
Target $103
OPCO
Outperform
Amedisys price target raised to $103 from $85 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Amedisys to $103 form $85 after the company reported a Q2 beat and raise. The analyst reiterates an Outperform rating on the shares.
08/03/18
RBCM
08/03/18
NO CHANGE
Target $115
RBCM
Outperform
Amedisys price target raised to $115 from $77 at RBC Capital
RBC Capital analyst Frank Morgan raised his price target on Amedisys to $115 and kept his Outperform rating after its "impressive" Q2 beat. Morgan says the results were driven by the "solid organic growth in home health and hospice and margin expansion across the enterprise on operating leverage" coming from the general expense environment.

TODAY'S FREE FLY STORIES

MAR

Marriott

$110.04

-0.78 (-0.70%)

07:36
12/12/18
12/12
07:36
12/12/18
07:36
Downgrade
Marriott rating change  »

Marriott downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$12.67

-0.24 (-1.86%)

07:35
12/12/18
12/12
07:35
12/12/18
07:35
Recommendations
Mattel analyst commentary  »

Correction: Mattel not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

MYND

MYnd Analytics

$1.26

-0.04 (-3.08%)

07:35
12/12/18
12/12
07:35
12/12/18
07:35
Hot Stocks
MYnd Analytics appoints Patrick Herguth CEO, George Carpenter CIO »

MYnd Analytics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$24.58

-0.17 (-0.69%)

, T

AT&T

$29.70

-0.21 (-0.70%)

07:35
12/12/18
12/12
07:35
12/12/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$24.58

-0.17 (-0.69%)

T

AT&T

$29.70

-0.21 (-0.70%)

NIO

NIO Inc.

$7.05

0.03 (0.43%)

BX

Blackstone

$30.50

0.03 (0.10%)

KHC

Kraft Heinz

$48.38

0.1 (0.21%)

NBR

Nabors Industries

$2.82

0.12 (4.44%)

KKR

KKR

$20.92

-0.21 (-0.99%)

TROX

Tronox

$7.11

0.06 (0.85%)

MLCO

Melco Resorts & Entertainment

$17.36

0.35 (2.06%)

DLPH

Delphi Technologies

$16.07

0.26 (1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 18

    Dec

  • 30

    Jan

  • 12

    Feb

  • 20

    Mar

07:35
12/12/18
12/12
07:35
12/12/18
07:35
General news
U.S. MBA mortgage market index rose 1.6% »

U.S. MBA mortgage market…

AUDVF

Audi AG

$0.00

(0.00%)

07:34
12/12/18
12/12
07:34
12/12/18
07:34
Hot Stocks
Audi names interim CEO Bram Schot as chairman of the board »

The Supervisory Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTB

Cooper Tire

$30.71

0.12 (0.39%)

07:34
12/12/18
12/12
07:34
12/12/18
07:34
Hot Stocks
Cooper Tire, Sailun announce JV for new TBR tire plant in Vietnam »

Cooper Tire & Rubber…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDS

Aridis Pharmaceuticals

$7.96

0.02 (0.25%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Hot Stocks
Aridis Pharmaceuticals enrolls first subject in Phase 1/2a lung infection trial »

Aridis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$85.72

-0.14 (-0.16%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Hot Stocks
Neurocrine says valbenazine did not meet primary endpoint in Phase IIb study »

Neurocrine Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

O

Realty Income

$66.30

0.58 (0.88%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Upgrade
Realty Income rating change  »

Realty Income upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$33.95

1.285 (3.93%)

07:31
12/12/18
12/12
07:31
12/12/18
07:31
Conference/Events
Health Insurance Innovations to host analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

AQUA

Evoqua Water

$10.23

0.06 (0.59%)

07:31
12/12/18
12/12
07:31
12/12/18
07:31
Initiation
Evoqua Water initiated  »

Evoqua Water initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNTR

Pointer Telocation

$11.55

-0.25 (-2.12%)

07:30
12/12/18
12/12
07:30
12/12/18
07:30
Hot Stocks
Pointer Telocation and Pricol to form joint venture for telematics solution »

Pointer Telocation and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRT

Federal Realty

$133.31

0.43 (0.32%)

07:30
12/12/18
12/12
07:30
12/12/18
07:30
Downgrade
Federal Realty rating change  »

Federal Realty downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

GE

General Electric

$6.77

-0.15 (-2.17%)

, F

Ford

$8.54

0.015 (0.18%)

07:30
12/12/18
12/12
07:30
12/12/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

GE

General Electric

$6.77

-0.15 (-2.17%)

F

Ford

$8.54

0.015 (0.18%)

SLB

Schlumberger

$41.24

-0.72 (-1.72%)

KO

Coca-Cola

$49.54

0.29 (0.59%)

ACB

Aurora Cannabis

$5.93

0.22 (3.85%)

FSLR

First Solar

$42.43

-0.79 (-1.83%)

UA

Under Armour

$20.87

-0.15 (-0.71%)

QSR

Restaurant Brands

$52.98

-0.81 (-1.51%)

GRMN

Garmin

$65.37

0.41 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 18

    Dec

  • 18

    Dec

  • 18

    Dec

  • 18

    Jan

  • 23

    Jan

  • 03

    Mar

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

H

Hyatt

$67.43

-1.41 (-2.05%)

07:29
12/12/18
12/12
07:29
12/12/18
07:29
Downgrade
Hyatt rating change  »

Hyatt downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HST

Host Hotels

$17.97

-0.13 (-0.72%)

07:28
12/12/18
12/12
07:28
12/12/18
07:28
Downgrade
Host Hotels rating change  »

Host Hotels downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEE

NextEra Energy

$183.05

0.33 (0.18%)

07:28
12/12/18
12/12
07:28
12/12/18
07:28
Recommendations
NextEra Energy analyst commentary  »

NextEra Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$85.72

-0.14 (-0.16%)

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Hot Stocks
Breaking Hot Stocks news story on Neurocrine »

Neurocrine trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Recommendations
Tesla analyst commentary  »

Tesla poised to exceed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

LULU

Lululemon

$116.67

1.66 (1.44%)

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Upgrade
Lululemon rating change  »

Citi upgrades Lululemon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

UAA

Under Armour

$22.14

-0.25 (-1.12%)

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Conference/Events
Under Armour to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 14

    Dec

UA

Under Armour

$20.87

-0.15 (-0.71%)

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Conference/Events
Under Armour to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 03

    Mar

AIMT

Aimmune

$23.25

0.18 (0.78%)

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Conference/Events
Aimmune to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

EBAY

eBay

$29.05

0.07 (0.24%)

07:24
12/12/18
12/12
07:24
12/12/18
07:24
Downgrade
eBay rating change  »

Morgan Stanley admits to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.